100 related articles for article (PubMed ID: 480184)
1. Effects of clofibrate and warfarin alone and in combination on the disposition of vitamin K1.
Bjornsson TD; Meffin PJ; Swezey SE; Blaschke TF
J Pharmacol Exp Ther; 1979 Sep; 210(3):322-6. PubMed ID: 480184
[TBL] [Abstract][Full Text] [Related]
2. Clofibrate displaces warfarin from plasma proteins in man: an example of a pure displacement interaction.
Bjornsson TD; Meffin PJ; Swezey S; Blaschke TF
J Pharmacol Exp Ther; 1979 Sep; 210(3):316-21. PubMed ID: 480183
[TBL] [Abstract][Full Text] [Related]
3. Enantiomers of warfarin and vitamin K1 metabolism.
Choonara IA; Haynes BP; Cholerton S; Breckenridge AM; Park BK
Br J Clin Pharmacol; 1986 Dec; 22(6):729-32. PubMed ID: 3567019
[TBL] [Abstract][Full Text] [Related]
4. Effect of warfarin on plasma and liver vitamin K levels and vitamin K epoxide reductase activity in relation to plasma clotting factor levels in rats.
Yamanaka Y; Yamano M; Yasunaga K; Shike T; Uchida K
Thromb Res; 1990 Jan; 57(2):205-14. PubMed ID: 2315885
[TBL] [Abstract][Full Text] [Related]
5. The influence of (R)- and (S)-warfarin, vitamin K and vitamin K epoxide upon warfarin anticoagulation.
Kamali F; Edwards C; Butler TJ; Wynne HA
Thromb Haemost; 2000 Jul; 84(1):39-42. PubMed ID: 10928467
[TBL] [Abstract][Full Text] [Related]
6. A fibroblast cell culture model to study vitamin K metabolism and the inhibition of vitamin K epoxide reductase by known and suspected antagonists.
Ross PJ; Shearer MJ; Diplock AT; Schey SA
Br J Haematol; 1991 Feb; 77(2):195-200. PubMed ID: 2004021
[TBL] [Abstract][Full Text] [Related]
7. Formation of 3-hydroxy-2,3-dihydrovitamin K1 in vivo: relationship to vitamin K epoxide reductase and warfarin resistance.
Preusch PC; Suttie JW
J Nutr; 1984 May; 114(5):902-10. PubMed ID: 6726460
[TBL] [Abstract][Full Text] [Related]
8. Differential effect of the enantiomers of phenprocoumon and warfarin on the vitamin K1-epoxide/vitamin K1 ratio in rat plasma.
Schmidt W; Beermann D; Oesch F; Jähnchen E
J Pharm Pharmacol; 1979 Jul; 31(7):490-1. PubMed ID: 38329
[No Abstract] [Full Text] [Related]
9. Vitamin K1, vitamin K1 epoxide and warfarin interrelationships in the dog.
Carlisle DM; Blaschke TF
Biochem Pharmacol; 1981 Nov; 30(21):2931-6. PubMed ID: 7317089
[No Abstract] [Full Text] [Related]
10. Multivitamin supplements may affect warfarin anticoagulation in susceptible patients.
Kurnik D; Lubetsky A; Loebstein R; Almog S; Halkin H
Ann Pharmacother; 2003 Nov; 37(11):1603-6. PubMed ID: 14565795
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of diphacinone rodenticide toxicosis in the dog and its therapeutic implications.
Mount ME; Feldman BF
Am J Vet Res; 1983 Nov; 44(11):2009-17. PubMed ID: 6689111
[TBL] [Abstract][Full Text] [Related]
12. [Study on changes of serum vitamin K1 level and K dependent coagulation factors in patients with coumarin derivatives (warfarin) therapy].
Suzuki K; Shimazu C; Yasuda K
Rinsho Byori; 1992 Jul; 40(7):783-8. PubMed ID: 1507498
[TBL] [Abstract][Full Text] [Related]
13. Normal and warfarin-resistant rat hepatocyte metabolism of vitamin K 2,3-epoxide: evidence for multiple pathways of hydroxyvitamin K formation.
Trivedi LS; Rhee M; Galivan JH; Fasco MJ
Arch Biochem Biophys; 1988 Jul; 264(1):67-73. PubMed ID: 3395132
[TBL] [Abstract][Full Text] [Related]
14. Dose - response relationship between warfarin and the metabolism of phylloquinone (vitamin K1) in man.
Shearer MJ; McBurney A; Breckenridge A; Barkhan P
Int J Vitam Nutr Res; 1976; 46(2):215-9. PubMed ID: 1032634
[No Abstract] [Full Text] [Related]
15. Quantitation of radio-labelled vitamin K1 and vitamin K1 epoxide in plasma by high pressure liquid chromatography.
Bjornsson TD; Swezey SE; Meffin PJ; Blaschke TF
Thromb Haemost; 1978 Apr; 39(2):466-73. PubMed ID: 580994
[TBL] [Abstract][Full Text] [Related]
16. The interaction between vitamin K nutriture and warfarin administration in patients with bacterial overgrowth due to atrophic gastritis.
Camilo ME; Paiva SA; O'Brien ME; Booth SL; Davidson KW; Sokoll LJ; Sadowski JA; Russell RM
J Nutr Health Aging; 1998; 2(2):73-8. PubMed ID: 10993569
[TBL] [Abstract][Full Text] [Related]
17. Anticoagulant effects of warfarin and kinetics of K vitamins in blood and feces.
Nakamura K; Toyohira H; Kariyazono H; Ishibashi M; Saigenji H; Shimokawa S; Taira A
Artery; 1994; 21(3):148-60. PubMed ID: 7794122
[TBL] [Abstract][Full Text] [Related]
18. The effects of vitamin K1 and warfarin on prothrombin expression in human hepatoblastoma (HepG2) cells.
Jamison CS; Burkey BF; Degen SJ
Thromb Haemost; 1992 Jul; 68(1):40-7. PubMed ID: 1325077
[TBL] [Abstract][Full Text] [Related]
19. The relationship between inhibition of vitamin K1 2,3-epoxide reductase and reduction of clotting factor activity with warfarin.
Choonara IA; Malia RG; Haynes BP; Hay CR; Cholerton S; Breckenridge AM; Preston FE; Park BK
Br J Clin Pharmacol; 1988 Jan; 25(1):1-7. PubMed ID: 3370190
[TBL] [Abstract][Full Text] [Related]
20. Vitamin K activity and metabolism of vitamin K-1 epoxide-1,4-diol.
Bell RG
J Nutr; 1982 Feb; 112(2):287-92. PubMed ID: 7057266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
